Aberrant mitosis occurs in many tauopathy-related neurodegenerative diseases and is believed to precede the formation of neurofibrillary tangles (NFTs). In this study, we report for the first time that transient cerebral ischemia induces aberrant mitotic proteins and hyperphosphorylation of tau protein with NFT-like conformational epitopes in adult female rat cortex. Following transient cerebral ischemia in rats, initiation of apoptosis precedes and is potentially integrated with subsequent aberrant mitosis and tau hyperphosphorylation. Further, inhibition of mitosis-related cyclin-dependent kinases (Cdks) by roscovitine significantly reduced the hyperphosphorylation of tau.
Introduction
The prevalence of dementia in ischemic stroke patients is nine-times higher than controls at 3 months (Tatemichi, Desmond et al. 1992 ) and 4-12 times higher than i n controls at 4 years after a lacunar infarct (Loeb, Gandolfo et al. 1992 ). Many of these dementias developed progressively, and cerebral damage is believed to be the direct cause of cognitive decline in only half of these cases (Tatemichi, Paik et al. 1994) . AD is the most prevalent dementia (Pasquier and Leys 1997) and shares common neuropatho logy features with stroke. Amyloid angiopathy can lead to cerebral hemorrhage (Vinters 1987) , Alz-50-immunoreactive granules are found around cerebral infarction after a stroke (Ikeda, Akiyama et al. 2000) , amyloid precursor protein (APP) accumulates following transient focal ischemia (Shi, Yang et al. 2000) , and ApoE4 is a genetic risk factor for both AD and stroke (Contois, Anamani et al. 1996) .
Neurofibrillary Tangles (NFTs), whose major component is hyperphosphorylated tau (Goedert 1993) , are observed in many neurodegenerative diseases (Spillantini, Crowther et al. 1998; Spillantini and Goedert 1998) . Recent reports indicate that aberrant mitotic activation, as well as DNA replication, in terminally differentiated neurons appears to be involved in the pathogenesis of AD (Vincent, Zheng et al. 1998; Yang, 4 Feddersen, Ehle nfeldt et al. 1992; Enokido, Araki et al. 1996; Nuydens, de Jong et al. 1998 ). In AD and other tauopathy diseases, induction of Cdc2 and cyclin B1, as well as aberrant DNA replication, is observed in neurons containing NFTs (Yang, Geldmacher et al. 2001) . However, completion of successful nuclear divisions in differentiated neurons has never been reported. These inappropriately induced mitotic protein kinases can phosphorylate tau, modify other cytoskeletal proteins, and further induce apoptosis in terminally differentiated cells (Yen, Liu et al. 1995) .
Recent studies reveal an intricate interaction between apoptosis, mitosis and formation of NFTs in terminally differentiated neurons. Activation of programmed cell death is observed in AD brains. Apoptosis, as indicated by TdT-mediated dUTP NickEnd Labeling (TUNEL) (Katsuse, Iseki et al. 2001 ) positive neurons and activation of neuronal caspase-3 (Stadelmann, Deckwerth et al. 1999) , is widespread in AD brains.
Survivin, a member of the Inhibitor of Apoptosis Protein (IAPs) family, is induced under stress, as well as in the G2/M phase of the cell cycle and binds to spindle microtubules (Uren, Beilharz et al. 1999) . Up-regulation of cyclin D1 and other cell cycle progression markers, is observed during apoptosis in post-mitotic neuronal cultures (Shir van, Ziv et al. 1997; Sakai, Suzuki et al. 1999; Stadelmann, Deckwerth et al. 1999) , and cell cycle inhibitors are protective against apoptotic stimuli in neurons (Farinelli and Greene 1996) .
All above mentioned evidence indicates that mitotic events may contrib ute to the formation of AD pathology (Vincent, Rosado et al. 1996; Husseman, Nochlin et al. 2000) .
In the present study, we observed an induction of tau hyperphosphorylation, and mitosisrelated proteins, and assessed the temporal pattern and colocalization of markers of apoptosis, mitotic protein activation, and tau hyperphosphorylation in a rodent model for 
Materials Methods

Animals
Four-six week old f emale Sprague Dawley (SD) rats, were purchased from Charles Rivers (Wilmington, MA), and maintained in our animal facility in a temperature-controlled room (22-25°C) with 12-hour dark-light cycles. All rats have free access to laboratory chow and tap water. All animal procedures were reviewed and approved by the University of North Texas Health Science Center Institutional Animal Care and Use Committee.
Animal surgeries
All experimental animals received ovariectomies (Ovx) at least 14 days before any further surgical procedure. For middle cerebral artery (MCA) occlusion and reperfusion, an intraluminal filament model with slight modification was used (Bederson, Pitts et al. 1986; Simpkins, Rajakumar et al. 1997) . Briefly, the animal was anesthe tized with ketamine (60mg/kg) and xylazine (10mg/kg), then the internal carotid artery (ICA) was exposed, and a 3-0 monofilament nylon suture was introduced into the ICA lumen through a puncture and gently advanced to the distal internal carotid artery (ICA) until proper resistance was felt. After 1 hr, the suture was withdrawn from the ICA and the distal ICA was immediately cauterized. At the desired time after the onset of reperfusion (2, 4, or 24 hr) animals were sacrificed and sampled for immunoblotting, immunohistochemistry, or TTC stain, as described below. 7 MI), and stained by incubation in a 2% 2,3,5-Triphenyl-2H-tetrazolium chloride (TTC) in a 0.9% saline solution at 37 °C for 30 min. Photographs were taken with Kodak digital camera. Each treatment group included at least 3-4 animals.
Roscovitine administration
Rats were anesthetized with halothane and placed in a stereotaxic device. A surgical stainless steel microsyringe was temporarily inserted with following coordinates:
antero-posterior -5; lateral 1.8 from bregma; and -7.9 ventral from the dura, so that the tip of the syringe needle would be inserted into the third ventricle (Paxinos, Watson et al. 1985) . The insertion position was confirmed with post-mortem dissection. Animals were administered 50µl of 1mM roscovitine (Sigma-Aldrich, St Louis, WA) in 30% 2-hydroxypropyl-β-cyclodextrin (HPβCD) (equivalent to approximately 20µM initial final concentration of roscovitine in the brain) into the right lateral ventricle over a period of 5 min using a microinjection syringe. The needles were held in position for at least another 30 min to avoid leaking. Sham treated animals received an equal volume of 30% HPβCD. The animals were then allowed to rest at least 2 hr before further MCA surgery.
Estrogen treatments:
17β-Estradiol (Steraloids, Inc. Newport, RI) was dissolved in absolute ethanol and then diluted in corn oil (Penta Manufacturing airfield, NJ) at a concentration of 100µg/ml. Ethanol was evaporated by incubation at 60°C over night. A single subcutaneous injection of 100 µg/kg or vehicle was given to the rats 2 hr before MCA occlusion surgery. Igepal CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 1mM sodium orthovanadate, 10µg/ml Aprotinin, 100 µg/ml Phenylmethyl Sulphonyl Fluoride (PMSF)). Samples were centrifuged at 12,000g for 30 min, and supernatants were collected for analysis. Samples were probed with specific antibodies at proper dilutions with procedures according to the manufacturer's instruction. The blots were developed with an enhanced chemiluminescent kit (Pierce, Rockford, IL). In all immunoblots, each lane represented an independent experimental animal with described treatments.
Protein kinase assay
Cdc2-like kinase activity was examined with Signa lTECT cdc2 Protein Kinase Assay System (Promega, Madison, WI), according to manufacturer's instruction. Briefly 10µg brain extracts was incubated with cdc2-specific substrates in 20 µl of the protein kinase assay buffer together with 1µCi γ-32 P ATP (ICN Biomedicals, Inc. Irvine CA)
After 15 min of reaction at 30°C, the reaction was terminated by adding an equal volume of stop buffer, heated at 95°C. The result was obtained by counting in a liquid scintillation counter.
Immunohistochemical and immunofluorescent staining
For histological studies, we used paraffin-embedded brain sections (5-7µm thick)
that received transcardiac perfusion with 4% formaldehyde in PBS, followed by immersion fixation, then switched to 70% alcohol, for at least another 24-hr before paraffin-embedding. All single antigen detection was performed using an avidin-biotin 9 immune-peroxidase method with DAB substrate (dark brown) and Histostain plus kits (Zymed, Inc, South San Francisco, CA) according to the manufacturer's instruction.
Multi-antigen immuno-detection or colocalizations were achieved with either immunofluorescence with a variety of highly species-specific or isotype-specific nonoverlapping Alexa-fluorophore conjugated secondary antibodies (Molecular Probes, Inc.
Eugene, OR). Detection of fluorophore was achieved by fluorescent microscope or confocal microscopy. Some imuunofluorescent stainings were counter-stained with DAPI, a nuclear marker.
TUNEL assay and colocalizations with specific antigens
DNA fragmentation was detected by a TUNEL method using a Dead END fluorescent kit (Promega, Madison, WI) according to the manufacturer's instruction.
Colocalization with TUNEL staining was achieved by confocal microscopy described 
Sarcosyl tau extraction
Sarcosyl extraction was performed as described previously with slight modification . Briefly, brain tissues from ischemic and contralateral rat cortex were homogenized in 10 volumes of buffer consisting of 10 mM
Tris-HCl (pH 7.4), 0.8M NaCl, 1 mM EGTA, and 10% sucrose. The homogenate was centrifuged for 20 min at 20,000g. The supernatant was brought to 1% Nlauroylsarcosinate (Sarcosyl) and incubated for 1 hr at room temperature with moderate shaking. Samples were then centrifuged at 100,000g for 1hr at 4°C and the sarcosylinsolub le pellets were resuspended in 50 mM Tris-HCl (pH 7.4). Extracts are either temporally stored at 4°C, or at -80°C for long-term storage until use. This material was used for both immunoblotting and electron microscopy analysis.
Electron microscopy
Resuspended sarcosyl-insoluble materials obtained from ischemic cortical or contralateral extracts were placed directly on carbon-coated, 300-mesh grids, stained with 2% phosphotungstic acid, and analyzed by electron microscopy ).
As negative controls, filament preparations from contralateral extracts were examined at the same time. Microphotographs were recorded at an operating voltage of 80-100 kV and at nominal magnifications of 160,000-400,000 on a Zeiss electron microscope.
Semi-quantitative cell counting
To estimate the density of cortical cells labeled with specific antibodies, methods were adapted from previous reports (Jiang, Gu et al. 2001) . Briefly, ischemic brain sections from animals that received roscovitine (n=6) or sham treatment (n=3) were
Results
Cerebral ischemia-reperfusion rapidly induces apoptosis and subsequent mitotic events
MCA occlusion is a widely used ischemic stroke model (Bederson, Pitts et al. 1986 ). This in vivo model for neuronal death has the distinct advantage that apoptosis is rapidly induced and synchronized in a large number of neurons (Li, Chopp et al. 1997 ).
Initially, we examined the effects of transient cerebral ischemia on apoptosis and the expression of mitotic markers. As early as 2hr after the initiation of reperfusion following a 1hr ischemia, positive TUNEL-staining appeared in the core ischemic region within the basal ganglion, but no mitotic markers were observed in the neurons in the ischemic region ( Fig. 1A) . At 4hr of reperfusion, the brain areas and number of cells displaying TUNEL-positive staining had increased. At the same time, expression of mitotic markers, cyclin B1 and MPM-2, appeared in the ischemic core (Fig. 1B, 1D ), and these markers extended into parts of the cortex around the infarct area (data not shown). Cyclin B1 is the activator of Cdc2 protein kinase, and accumulates during mitosis (Fang and Newport 1991) , and the MPM-2 monoclonal antibody recognizes a set of M -phase specific phosphoproteins, most of which are the substrates of Cdc2/cyclin B1 (Davis, Tsao et al. 1983) . No phospho-epitopes of tau were detected at 4hr of reperfusion after MCA occlusion in either the ische mic region or the contralateral brain side (data not shown).
Aberrant mitotic proteins associate with delayed cell death
The ischemia-reperfusion injury showed that both density and intensity of TUNEL-positive staining progressed with time and was evident throughout the infarcted brain region at 24hr of reperfusion (Fig 1) . The TUNEL signals were not present in the 13 contralateral hemisphere ( Fig. 2A ), but were abundant in both the core region ( Fig 1C) and the cortical areas (Fig. 2B, 2C ). In parallel, we also observed a marked induction of both the mitotic epitopes (MPM-2) and the mitotic proteins cyclin B1 in the ischemic area. In the hemisphere contralateral to the occlusion, these mitotic epitopes were absent ( Fig. 2A) . However, on the ischemic side, these mitotic epitopes were widespread and intensely stained (Fig. 2) . Most of the mitotic epitopes had cytosolic distributions with a few instances of nuclear localization. This observation is consistent with previous research in AD patients (Husseman, Nochlin et al. 2000) . (Fig. 2C ).
To further evaluate the co-localization of TUNEL and mitotic markers and to identify cell types containing these markers, we performed semi-quantitative counting (Fig 2E-F We further assessed ischemic brain sections of animals that had undergone transient ischemia with a variety of antibodies that detect tauopathies in neurons affected with human AD. These monoclonal antibodies were directed against distinct phosphorylation sites and/or conformational states of tau protein present in AD brains (Goedert, Jakes et al. 1994) . The transient cerebral ischemia induced not only hyperphosphorylation, indicated by PHF-1 (Fig. 3C ) and CP13 (Fig. 3D ), but also the unique tauopathy conformational change, indicated by MC1 (Fig. 3A) and TG3 (Fig. 3B ).
The NFTs were expressed throughout the ischemic area, with the most intense immunoreactivity observed in the frontoparietal cortex (Fig. 3 A-D) , in a pattern similar to cyclin B1/MPM-2 staining. Although there was evidence of cell shrinkage and nuclear condensation, these NFT-positive cells still had an apparent neuronal morphology, and most of the immunoreactivity was localized in the cytoplasm (Fig. 3 A-D) . Immunoblot analysis of cortical extracts revealed a marked induction of NFT-specific epitopes in cortical areas affected by MCA occlusion-induced ischemia compared with the control areas of the contralateral cortex (Fig.3 E) . Further analysis of sarcosyl-extracted tau extracts by electronic microscopic analysis showed evidence of aberrant paired-helical filaments similar to that found in AD patient brain extracts. However, defined tangles and senile plaques, as identified with modified Gallyas silver and thioflavin-S staining were not detected.
Previous studies have demonstrated that tau can be phosphorylated by a number of protein kinases (Pelech 1995) . We examined some candidate protein kinases involved in tau hyperphosphorylation. We observed an increase in Cdc2 protein kinase levels ( Fig.   4A ), as well as an increase in its kinase activity (Fig 4B) . The corresponding activator of Cdc2, Cyclin B1 also showed a marked induction (Fig. 4C) . Cdk5, GSK3-β, and pERK levels in cortical extracts from animals at 24 hr after MCA occlusion were not significant changed.
Co-localization of markers of apoptosis, mitosis and NFTs
To further understand the spatial relationship of the apoptotic, mitotic, and NFTs, we examined the colocalization of these markers in the frontoparietal cortex in the penumbra areas. These markers highly colocalized with each other in cortical pyramidal neurons in the peri-infarct areas. Double staining of NFTs and TUNEL revealed that that TUNEL-positive signals colocalized with 30-70% NFT-positive cells (Fig. 5 ).
Roscovitine, a potent mitotic Cdk inhibitor, reduces tau hyperphosphorylation in the ische mic cortex
In order to further confirm the relationship of this tau hyperphosphrylation and aberrant cell cycle, we administered roscovitine, a potent cyclin-dependent kinase inhibitor (K i =0.2-0.7µM), into the lateral ventricle. The effect of this treatment was evaluated by examining the mitotic epitopes with MPM2 labeling (Fig. 6A) . The treatment reduced the MPM2 epitope from an average of 38.4 ± 4.4% in sham-treated animals to an average of 9.9 ± 2.3% in roscovitine-treated animals in frontoparietal cortex ( Fig 6B) . We also noticed a reduction in average staining intensity, which was difficult to evaluate quantitatively.
In order to evaluate roscovitine's effects on tau hyperphosphorylation, we performed semi-quantitative cell counting in the frontoparietal cortex. Roscovitine treatment reduced PHF-1-positive cell number in the ischemic cortical regions from an average of 23.24 ± 3.0% to in sham-treated to 5.9 ± 1.4% in roscovitine-treated animals (Fig. 7A, 7B ).
17-β β estradiol reduces ischemic damage, abe rrant mitosis and NFT epitopes
To determine the correlation between ischemic damage and NFT formation, we assessed the responses to MCA occlusion in the presence of a known anti-apoptotic agent, 17 β-estradiol. Estrogen treatments have been demonstrated t o be effective in protecting greater than 50% of ischemic brain tissues from MCA occlusion-induced apoptosis (Simpkins, Rajakumar et al. 1997; Behl 2002; Wise 2002 ). 2,3,5-Triphenyltetrazolium chloride (TTC) staining was used to reveal the extent of the infarcted area after ischemia-reperfusion (Fig. 8A) . 17 β-estradiol treatments in this stroke model reduced the ischemic volume by about 50% (Fig. 8A ) and caused a similar reduction in TUNEL staining (Fig. 8A ) in the ischemic areas. We found that this treatment significantly reduced the expression of the mitotic protein, cyclin B1 (Fig. 8B) and of NFT epitopes in cortical brain extracts from the ischemic cerebral cortex (Fig.   8C ). in the initiation and progression of neurodegeneration remains controversial (Vincent, Rosado et al. 1996) . Transgenic mice that host the familial disease mutations in amyloid precursor protein (APP) and/or presenilins developed senile plaques, but lack NFTs and exhibit little neuronal loss (Goate, Chartier-Harlin et al. 1991; Sherrington, Rogaev et al. 1995; Holcomb, Gordon et al. 1998 ). This suggests that the development of senile plaques and NFTs may have independent causative mechanisms or require involvement of further factors during the pathogenesis of AD. It has been well documented that tauopathy-related neurodegenerative diseases involve the induction of aberrant mitotic proteins in affected neurons (Vincent, Jicha et al. 1997; Husseman, Nochlin et al. 2000; Raina, Zhu et al. 2000) . The mitotic kinase and its activators, as well as other mitotic phosphoepitopes, accumulate in degenerating neurons that contain the characteristic structural lesions of AD (Vincent, Rosado et al. 1996; Husseman, Nochlin et al. 2000) .
The common appearance of mitotic proteins and NFTs in neurodegenerative diseases and their coincident appearance in cells suggest that mitotic proteins are involved in the hyperphosphorylation of tau and could be responsible for the initialization and progression of NFTs in affected neurons.
In the present study, we identified aberrant tau hyperphosphorylation and NFTlike conformational epitopes from ischemic rat brains. There is still insufficient evidence that the transient ischemia-induced NFTs are identical to those in AD brains. Rat tau proteins are not identical to the human tau (Kanai, Takemura et al. 1989) , and our electronic microscopic analysis of the sarcosyl-extracted tau revealed only a small fraction with filamentous conformation. Furthermore, we failed to identify Gallyas silver including the recent triple transgenic animal study that indicate that amyloid deposition and synaptic dysfunction precedes the formation of plaques that contains NFTs (Oddo, Caccamo et al. 2003) .
Previous research indicates that cell cycle signaling mechanisms are involved in neuronal apoptosis (Shirvan, Ziv et al. 1997; Nuydens, de Jong et al. 1998; Sakai, Suzuki et al. 1999 ). This apoptosis-related i nduction of cell-cycle proteins in post-mitotic neurons has been studied in both in vitro and in vivo models (Nuydens, de Jong et al. 1998; Lin, Chong et al. 2001) . In post-mitotic neurons of the adult brain, active mitotic kinase complexes can induce an abortive or a catastrophic M-phase and eventually lead to cell death. Ischemic neuronal death may involve cell cycle signaling. Cyclin D1, cyclin by guest on January 1, 2018
http://www.jbc.org/ Downloaded from 20 G1, PCNA and p21 waf1/cip1 are reported to be activated in vulnerable neurons following transient global ischemia (Tomasevic, Kamme et al. 1998; van Lookeren Campagne and Gill 1998). Mitotic protein induction and DNA replication have been well established in AD patient neurons in many studies (Yang, Geldmacher et al. 2001; McPhie, Coopersmith et al. 2003) .
The activation of mitosis-related protein complex in the neurons may be fundamental to the progression to neuronal death and to the expression of NFT pathology (Vincent, Rosado et al. 1996; Husseman, Nochlin et al. 2000) . Tau protein is a high affinity substrate of Cdc2 (Paudel 1997) . In differentiated neurons, Cdc2-induced phosphorylation of tau inhibits its binding to tubulin and reduces the stability of the cytoskeleton (Lu, Wulf et al. 1999) . Nucleolin, another Cdc2 substrate, is crucial for ribosomal biogenesis and cytoplasmic-nuclear shuttling of RNA, and may also contribute to AD pathology (Dranovsky, Vincent et al. 2001) . During mitosis in dividing cells, phosphorylation of these mitotic substrates is necessary for dynamic microtubule reorganization. However in differentiated neurons this mitotic protein activation may contribute to cell death signaling and initiate the formation of tau hyperphosphorylation.
Indeed, DNA degradation and caspase activation are increased in both AD and other degenerative disorders and these events are suggested to play a key role in the pathogenesis of these diseases (Marx 2001) .
Estrogens are potent anti-apoptotic agents against a variety of insults (Green and Simpkins 2000) . Our ability to prevent apoptosis and reduce mitotic proteins and NFTs with an 17 β-estradiol pretreatment suggests that prevention of the generation of signaling components upstream of apoptosis can also prevent or diminish subsequent mitotic and tau hyperphosphorylation responses to an i schemic event. Since initiation of apoptosis is an early event that eventually leads to tau pathology, anti-apoptosis therapeutic strategies are reasonable approaches to the prevention of NFT formation. By inference, therapies aimed at prevention of NFTs, that do not treat apoptosis and cell cycle protein activation may not be effective.
Our studies show that roscovitine treatment suppresses ischemia-induced tau hyperphosphorylation, suggesting the involvement of mitotic complex in this event. It is difficult to clearly identify a causative relationship between neuronal apoptosis, cell-cycle re-entry and hyperphosphorylation of tau, in part because n euronal apoptosis is not a single event, but a process that includes a number of signaling cascades and responds to a variety of stimuli. However, several of our observations indicate that these 3 processes are intimately connected and may be initiated by the ischemic event. First, neuronal apoptosis precedes aberrant cell-cycle protein induction (Fig. 1) . Second, the antiapoptotic agent, 17β-E2, reduces apoptosis and aberrant cell-cycle induction (Fig. 8) .
Finally, roscovitine, a cyclin-dependent kinase inhibitor, appear to reduce apoptosis ( 
